µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æרҵ£º F%^)oQT+c
4g^X
e-
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ &_W~d0
#f-pkeaeq
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) 5tQZf'pHfd
RSK5 }2
1. ICAM-1 XAw0Nn
%+0V0.
2. interleukin 12(IL-12) B`?}jJa9*
>dYN@cB$}
3. tumor infiltrating lymphocyte q3}WO]TBj
cPbAR'
4. TCR/CD3 complex G%5ZG$as
> xie+ ^
5. hematopoietin receptor family lNba[;_
^SC2k LI
6. individual idiotype(IdI) =u
3YRqz
L. DD
7. integrin 3:"w"0[K3
Z,1b$:+
8. colony-stimulatory factor (CSF) U\GuCw
+sFpIiJg
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© (Qf. S{;
A5?q&VS}p
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? ><i: P*ht
7^W(e s
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ gAr
=fq-|
ToX--w4
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷ÓᣠPWk\#dJN&
C2C1 @=w
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØϵ¡£ 2Og<e|
]\m>N]P]
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) %&j\:X~A
`!Yd$=*c_&
1. ÊÔÊö¸ÉÈÅËصķÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌص㡣Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËؼì²âµÄ·½·¨ºÍÔÀí¡£ ,Q<mU4
'Y0h w
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ä¿Ç°¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æרҵ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) X^Fc^U8
qs!A)H#
3. immunoglobulin superfamily (IgSF) Vw]!Kb7tA
xauMF~*
4. selectin mgMa)yc!dp
yw1-4*$c
5. anti-idiotypic antibody (¦ÁId) 3,?LpdTS
2Q 5-.2]
6. major histocompatibility complex(MHC) gI!d*]{BP
{krBAz&
7. immunotolerance 9oYE
?j&ZzK'#^
8. biological reponse modifier(BRM) WK0:3q(P
Z/czAr@4
9. immune reponse gene (Ir gene) vi28u xc
Fw:_O2
10. reshaped antibody (or reconstituted antibody) ,0c]/Sd*p
ST2:&xH(
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© aWPf3Q
i+F*vTM2,
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ '{-Ic?F<P
cyo[HI?WM
2. ϸ°û¶¾ÐÔTÁÜ°Íϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? 33; '6/
(%OZ `?`
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ Zrp-Hv27,,
UVXSW*$
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? W*%(J$E
AOJ[/YpM
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ Np i)R)
_a f $0!
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? uq;yR[w"
I,<?Kv
2. Ä¿Ç°µ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ R$+p4
@?S
JEaTDV_
¹©Ïû»¯ÄÚ¿ÆרҵÊÔÌ⣺ ;6~5FTmV
=H3tkMoi2
1. Ä¿Ç°ÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? I)y
F!E &
H>W8F2VT
2. Ä¿Ç°µ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ MB7*AA;
5\=
y9Z- x
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æרҵ: p_(En4QSH
rwVp}H G
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: &q@brX<,=
%<x!mE x
̉񧄤 Uqb]&2
d,?Tq
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© BjagG/sX
;g? |y(xv
1. CD8 /s~S\dG
M2N8?Ycv3
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) WubV?NX;EF
b,YNCb]H
3. immunoglobulin fold(Ig fold) %T\hL\L?
huS*1xl
4. cadherin (Ca-dependent cell adhesion moleculers) )Z:D}r8[
Ei):\,Nv
5. idiotype-anti-idiotypic antibody immune network theory QxdC[t$Lp
9aY8`
B
6. HLA class II antigen W.?/p~
"GQ Q8rQ
7. complementarity-determining region (CDR) qSB&Q0T
*dw.Ug
8. perforin(or pore-forming protein ,PFP) [)1vKaC
{\(MMTQ
9. high affinity IL-2 receptor Y55u-9|N
QJRnpN/
10. artificial active immunization T" W<l4i-
ro\
oL
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© p>;@]!YWQ
MCmb/.&wu
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠrobg1
qrYbc~jI7
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 _E`+0;O
YE{ [f@i0
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ z6C(?R
;na%*G`
4. ÊԱȽÏT¡¢BÁÜ°Íϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃ濹ԡ¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ > 0MP[
31a,i2Q4
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐÑ¡Ò»Ìâ,3¡¢4ÌâÖÐÑ¡Ò»Ìâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ä¿Ç°¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ d"9tP&
Q
&Mk!qE<:N
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? M`H#Qo5/
heCM+=#~
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ bTc>-e,
:rVR{,pL
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ #dWz,e3
sv%X8
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ v'@gUgC
{r&mNbz
ѧ¿Æרҵ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ Swhz\/u9
$72eHdy/yl
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 6DHK&<=D8
DWt|lO
1. immunoglobulin gene rearrangement rUb{iU;~m
0+FPAqX
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) [<RhaZz
]!B0
= XP
3. flow cytometry(FCM) 4^L;]v,|7
Y\]ZIvTSb
4. carrier effect ~v;I>ij
.5
.(S^u
5. positive selection of T lymphocytes in thymus ,TQec:B
+#FqC/`l
6. mouse TH1(Th1) and TH2(Th2) subsets %} `` :
e"S?qpJK
7. perforin (pore-forming protein ,PFP) E )_n?>Ar
zr.\7\v
8. ADCC(antibody-dependent cell-mediated cytotoxicity) Fc5.?X-
Tz @=N] D
9. SH-2(src-homology region 2) @|b-X? `
^1S{::
10. Ab2¦Â (internal image) TJ"-cWpO1
lmeTW0U@9(
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© x6UXd~
L
e
/+Z*)q+SbT
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? xb,d,(^ ]R
%~!4DXrMk
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? Ul}RT xJ
kUd]8Ff!
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠa{nR:zPE
M =^d
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ nI*.(+h
(7Z+ De?
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠ2l<2srEK
/$c87\
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) :
21d
<V&0
GAZ
ÃâÒßѧרҵ£º ZNQx;51
b@Oq}^a&o
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ 2aYBcPFQh#
%(YQ)=w
2. ÊԱȽÏÈËT¡¢BÁÜ°Íϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? 6
VEB2F
p!UR;xH
I\
´«È¾²¡Ñ§×¨Òµ£º j
"qND=15
nTy]sPn
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦ÄÜ¿É·¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ c{M
,K
( /]'e}
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØϵ¡£ Uy?jVPL
#3&@FzD_P
Ïû»¯×¨Òµ£º $[|(&8
+7
T\l`Y-vu
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ ^ij0<*ca9
h( | T.
2.¼òÊöճĤÏà¹ØÁÜ°ÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌص㡣·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? X-["{
QEyL/#Q
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ ;(i6 X)
@](vFb
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© :;{M0
:&BPKqKp
1. Fas(CD95)/FasL "Rj
PTRe:
YSD G!
2. common chain of cytokine receptor @|
z _&E
2 @#yQB1
3 . TCR/CD3 complex V*?cMJ_G
h@%Xy(/m'
4. negaive selection of thymocytes +C
SpL2@
P $`
1}
5. artificial active immune Dz }i-tw+
JxVGzb`8
6. anti-idiotypic @)Vpj\jM-C
#UM,)bH
7. IgSF alb3oipOB
<6Q^o[L
8. Integrin %-n)L
3%POTAw%
9. chemokine ~5HkDtI)
L)'G_)Sl
10. B7/CD28 7By7F:[ b
aT0~C.vT
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© un "I
<9@n/
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ 3BMz{ny=
opa/+V3E4
2. ±È½ÏCTLºÍNKɱÉË°Ðϸ°ûʱʶ±ðºÍɱÉË»úÖƵÄÌص㡣 '{d_q6,%
T~UDD
3
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 0+\725DJ
S`-I
-VS=L
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆʵÑé·½°¸¿Ë¡´Ë»ùÒò¡£ hW*o;o7u
+<E#_)}`D6
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ >iTmILA
S1=P-Ao
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ fN2Sio:
,M.C]6YMr
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 2s}S9
R}oN8
1. B7/CD28 @5Tl84@Q
<K)]kf
2. Th1 subset ;+75"=[YT
u
7e$Mq
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© CPZ{
#Y= A#Yz,{
4. antibody affinity maturation "kApGNB
&N.pW=%,N
5. AP-1 YKe&Ph.
3,i j@P
6. single chain variable fragment£¨ScFv£© NDRDP D
[#KY.n
7. NK cell receptor
c|<F8n
.vHHw@
8. Zinkernagel-Doherty phenomenon &r[f ;|o
CDJ@Tdp
9. Ig fold K+Him]
b
sm18u-
10. CD40/CD40L 8R)K$J$Hm
";.j[p:gi
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© [>NMuwtG
|-JG _i
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØϵ¡£ 9swHa
feXo"J
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ ]fb@>1
jp
^S|qGu,G
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹Øϵ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ F,vkk{Z>
+VVn@=&?
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ J>R$K
|}{gE=]
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁÜ°Íϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ 4lPO*:/
+1#oVl
!
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ M?8s
y
p+g=Z<?`
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æרҵ£©¡£ qBF|' .$^
QE/kR!r
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© 5H Cw%n9
f5//?ek
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© bB0/FiY7o
:PV3J0pB~
1.Co-stimulators (or co-stimulating molecules) 1E$\&*(
In4VS:dD
2.NK-kB
wYe;xk`>
M2V`|19Q
3.Immunoglobulin superfamily OfrzmL<K
H6Zo|n
4.antigen-presenting cell (APC) ~NE`Ad.G
/w?zO,!
5.death domain !L+b{
h>>~B i
6.CCR and CXCR ?6"U('y>n
v~
x`a0
7.Lectin (or mitogen) {|$kI`h,3-
s5v}S'uO{
8.Clusters of differentiation, CD) N[-$*F,:_
d_ :f-
9.B7 family Dy5&-yk
'_Q';T_n99
10.Cytotoxic T lymphocyte, CTL) G_qt~U
%<+Ku11
11.IL-15 and IL-15 receptor (IL-15R) 16N|
6Ik
v}q_j
12.MHC restriction P_H2[d&/>D
@/N]_2@8;
13.Affinity-chromatography >bI\pJ
[OPF3W3z
14.Cyctosprin A, CsA 'Sgz\=K
s(Wys^[g
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) |F\fdB}?S:
i"
+TKo-
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© QxbG-B^)=
./zzuKO8XK
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 =/xx:D/
Ll%}nti
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ X%og}Cfi
FWp ?l
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 eu]qgtg~U
Z6
-
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© z[vu-f9
*q\>DE=7
ÃâÒßѧרҵ£º mBB"e"o
<e
S+3,
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ A"qDc
)p#L "r^)
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ !?J-Y
8$ RiFD,
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ e]dFNunFq0
xh#pw2v7V
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) CbxWK#aMmB
F|'u0JQ)$
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) tnBCO%uG
Q.3
:"dT
1. ADCC(antibody dependent cell-mediated cytotoxicity) a3A3mBw
zN)) .a
2. »·æß¾úËØ(cyclosporin) X(.[rC>
c4Q9foE
3. KIR(killer cell inhibitory receptor) WjSu4
=\MAz[IDj
4. HLDA(human leucocyte differentiation antigen) ^wwS`vPb
z
yp3+|
5. Interleukin 18(IL-18) <
$Sl%DoS
YdIZik
F#
6. ÕûºÏËØ(integrin) <u],R.S)
Lm<WT
*@
7. Fas/FasL \P"Ol\@
9KJ}Ai
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) Z.x]6
LCzeE7x
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) 9:=:P>
m],.w M8
10. Th1/Th2 ,&fZo9J9
C?W}/r[
11. »ùÒòÒßÃç(DNAÒßÃç) P*U^,Jh<
yOAC<<Tzus
12. chemokines and chemokine receptor f/\S:x-
B
-okq=9
13. ÃâÒßÄÍÊÜ a"t~K
Zw'050~-
14. ¹²´Ì¼¤·Ö×Ó vfXNN F
;+#Nb/M
15. ËÀÍö½á¹¹Óò(death domain) SXvflr] =m
%3"U|Za+
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) EgbH{)u
mI:^lp
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉË°Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? o61rTj
Q00v(6V46
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»Æƶø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦ÓᣠnII#uI/!q
R?2HnJh
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î )^"V}z
t
y9LO;{(
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ ^Pu:&:ki
^K_FGE0ec
£¨3£©1984Ä꣺ÁÜ°Íϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå '=\>n(%Q
~F-lO1
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄЩÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ I3'UrKKO
h+Yd
\k
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) i:jB
/0fHkj/J=B
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ !y>up+cRjl
T}29(xz-(h
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ '|), ?
4~ L1~Gk
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆһϵͳʵÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃÇ°¾°¡£